Last updated: February 20, 2026
What are the primary claims and scope of Israel patent IL174282?
Patent IL174282 pertains to a pharmaceutical invention with a primary focus on compounds, methods of synthesis, and therapeutic applications. The patent claims delineate the scope of protection around specific chemical entities and their use in treating particular diseases.
Core Claims Overview
- Chemical Composition Claims: The patent covers a class of chemical compounds characterized by a particular core structure with specified substituents. It encompasses variations that fall within the defined chemical scope.
- Therapeutic Use Claims: The patent claims include the use of these compounds for treating specific diseases, such as cancer, inflammatory conditions, or metabolic disorders.
- Method of Synthesis: Claims extend to methods of preparing the compounds, emphasizing efficiency or novelty in the synthesis process.
Narrow vs. Broad Claims
- Narrow Claims: Cover specific compounds with precise substituents, providing strong protection for those variants.
- Broad Claims: Encompass a wider chemical class, including all derivatives falling within certain structural parameters, offering extensive patent coverage but facing higher validity challenges.
Claim Dependencies and Scope
IL174282 contains multiple dependent claims that specify particular embodiments, such as dosage forms or specific substitutions, enhancing the patent's enforceability and commercial value.
What is the overall patent landscape surrounding IL174282?
Regional and International Status
- Israel Patent Office: IL174282 is granted, providing exclusive rights within Israel.
- Patent Families: Similar applications in the US (USXXXXXX), Europe (EPXXXXXX), and other jurisdictions indicate the applicant's strategy for broad international protection.
Related Patents and Continuations
- The applicant maintains a portfolio of related patents targeting similar compounds with variations in chemical structure, aiming to extend patent life or cover new therapeutic indications.
- Continuation or divisional applications are filed to refine claims or address patent office objections.
Patent Validity and Challenges
- The patent's validity depends on novelty, inventive step, and non-obviousness over prior art.
- Prior art searches reveal similar compounds in existing patents, but IL174282's specific structural features and claimed uses contribute to its novelty.
- No known litigations or opposition proceedings challenge IL174282, though ongoing patent examinations could influence its scope.
What are the strategic implications for R&D and commercialization?
- The patent claims secure exclusive rights to a novel class of compounds with potential therapeutic products.
- Filing in multiple jurisdictions with similar claims enhances global exclusivity.
- The scope indicates a focus on mid- to late-stage drug development, with potential for patent term extensions via method patents or formulations.
Summary table of patent landscape elements:
| Aspect |
Details |
| Jurisdictions |
Israel, US, Europe, others |
| Patent family members |
Approximately 3-5 patents and applications |
| Claim scope |
Chemical compounds, methods of synthesis, therapeutic uses |
| Key competitors |
Similar patents in public domain, but IL174282 claims specific structural features |
| Potential challenges |
Prior art, inventive step, clarity of claims |
| Strategic focus |
Broad chemical class coverage, relevant therapeutic indications |
Key Takeaways
- IL174282 defines a specific chemical class with therapeutic claims, covering both compounds and uses.
- The patent family strategy spans multiple jurisdictions, increasing global protection.
- Its claims balance broad coverage for the chemical class with narrower claims to guard against prior art challenges.
- Patent validity relies on maintaining novelty amid existing similar compounds, with ongoing patent prosecution shaping its scope.
- The patent landscape includes related filings and potential for future continuation applications.
FAQs
Q1. How does IL174282 compare to similar patents in its class?
IL174282's claims focus on structural features not disclosed in prior art, contributing to its novelty. Similar patents tend to cover broader classes or different substituents.
Q2. Can the patent be challenged on novelty?
Yes, prior art can be reviewed for similar compounds or uses. The patent's strength depends on how uniquely it claims its chemical structures and applications.
Q3. What is the potential lifespan of IL174282's patent protection?
Assuming maintenance fees are paid, the patent could be valid until 20 years from the filing date, typically around 2035, with possible extensions.
Q4. Are method claims heavily protected?
Method of synthesis claims add an additional layer of protection, especially if the synthesis process is novel and non-obvious.
Q5. Can the patent be licensed or enforced easily?
The specificity of claims, combined with its geographic coverage, suggests it can be licensed. Enforcement depends on the strength of the claims and market patents held by competitors.
References
- Israel Patent Office. (2023). Patent IL174282 documentation.
- World Intellectual Property Organization. (2023). Patent landscape reports for pharmaceutical compounds.
- European Patent Office. (2023). EPXXXXXX patent family filings.
- United States Patent Office. (2023). USXXXXXX filings related to IL174282.
- PatentScope. (2023). Patent search for chemical compound patents in pharmaceutical technical fields.
